Conclusion
The incidence of SCEs remains at 23.1% in patients on uninterrupted OAC for AF ablation. LAD, baseline ACT, and time to reach optimal ACT are significant risk factors for SCE. Intra-procedural ACT kinetics vary among anticoagulants, which should be considered when estimating the risk of SCEs.